BeStock  
Markets › Compare › KYMR vs BMRN

KYMR vs BMRN

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
KYMR · Kymera Therapeutics$115.31 ▼ 3.42%
BMRN · Biomarin Pharmaceutical$60.41 ▼ 1.64%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

82116151185219Nov 24, '25May 26, '26Nov 20, '26
  • KYMR +75.8%
  • BMRN +8.8%

Head to head

MetricKYMRBMRN
Price$115.31$60.41
Change today▼ 3.42%▼ 1.64%
Market cap$9.84B$11.70B
Return, 3 months-4.7%-7.2%
Return, year to date+48.2%+1.6%
Return, 1 year+74.6%+10.5%
P/E (TTM)––
P/B6.11.9
P/E percentile vs own 5y3rd0th
Dividend yield––
Revenue growth (YoY, latest qtr)-100.0%+32.0%
Net profit growth (YoY)-60.6%-299.5%
Gross margin–76.0%
Operating margin-396.0%4.9%
Net margin-341.8%-0.5%
Return on equity-27.3%-0.3%
Analyst target vs. price+30.7%+46.9%
Analyst buy share100%74%
RSI (14)4159
30-day volatility51.7%31.8%
Max drawdown, 1 year-27.7%-22.6%
Trend readLeaning bearishStrong uptrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • BMRN is the largest of the group by market value.
  • KYMR has returned the most over the past year.
  • BMRN is growing revenue fastest.
  • BMRN keeps the most profit per dollar of sales.
  • BMRN has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top